You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CTMX Exercise Disclosure
Mccarthy Sean A. · SEC Form 4 · Filed Oct 16, 2026
Exercise
Calculated transaction value
$0
Mccarthy Sean A. CEO
CTMX
CytomX Therapeutics
CTMX
Transaction date
Nov 6, 2025
Public filing date
Oct 16, 2026
Filing lag
Filed 344 days later
CTMX daily price context
Close on/before transaction
$4.19
Nov 6, 2025
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 101,793 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4/A
- Filing identifier
- 0001610717-26-000442
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$623.76K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Cytomx Therapeutics, Inc. CTMX | Sale | Nov 6, 2025 | $461.91K |
| Cytomx Therapeutics, Inc. CTMX | Exercise | Nov 6, 2025 | $161.85K |
| Cytomx Therapeutics, Inc. CTMX Current | Exercise | Nov 6, 2025 | $0 |